Your browser doesn't support javascript.
loading
Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma.
Lou, Yun; Yu, Yue; Xu, Xiaolia; Zhou, Shu; Shen, Haiyuan; Fan, Tianlong; Wu, Di; Yin, Jie; Li, Guoqiang.
Afiliação
  • Lou Y; Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu province, China.
  • Yu Y; Key Laboratory of Living Donor Transplantation of Ministry of Public Health, Nanjing, Jiangsu province, China.
  • Xu X; Medical School of Southeast University, Nanjing, Jiangsu province, P.R. China.
  • Zhou S; Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu province, China.
  • Shen H; Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu province, China.
  • Fan T; Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu province, China.
  • Wu D; Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu province, China.
  • Yin J; Department of Respiratory Medicine, Jinling Hospital, Nanjing, Jiangsu province, China.
  • Li G; Department of Hepatobiliary Surgery of Drum Tower Clinical Medical College, Nanjing Medical University, Nanjing, China.
J Cell Mol Med ; 23(3): 1873-1884, 2019 03.
Article em En | MEDLINE | ID: mdl-30588744
ABSTRACT
Long non-coding RNAs (lncRNAs) play essential roles in diverse biological processes; however, current understanding of the mechanism underlying the regulation of tumour proliferation and metastasis is limited. Lung cancer-associated transcript 1 (LUCAT1) has been reported in a variety of human cancers, while its role in hepatocellular carcinoma (HCC) remains unclear. This study aimed to determine the biological role and underlying mechanism of LUCAT1 on progression and metastasis in HCC cells and clinical specimens. Our results demonstrated that LUCAT1 was up-regulated in HCC tissues and cells. Loss- and gain-of-function studies revealed that LUCAT1 promotes the proliferation and metastasis of HCC cells in vitro and in vivo. Furthermore, RNA pulldown and Western blot assays indicated that LUCAT1 inhibited the phosphorylation of Annexin A2 (ANXA2) to reduce the degradation of ANXA2-S100A10 heterotetramer (AIIt), which in turn accelerated the secretion of plasminogen into plasmin, thereby resulting in the activation of metalloprotease proteins. In conclusion, we propose that LUCAT1 serves as a novel diagnostic and therapeutic target for HCC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anexina A2 / Carcinoma Hepatocelular / RNA Longo não Codificante / Carcinogênese / Neoplasias Hepáticas Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anexina A2 / Carcinoma Hepatocelular / RNA Longo não Codificante / Carcinogênese / Neoplasias Hepáticas Idioma: En Ano de publicação: 2019 Tipo de documento: Article